Oncocross Amends 2025 Annual Report to Add Details of Financial Supervisory Service Penalties

Oncocross corrected its annual report filed on March 19, 2026, to include details of penalties imposed by the Financial Supervisory Service on July 10, 2025, consisting of fines of 72 million KRW and 15.3 million KRW.
The fines resulted from violations of securities registration requirements for the offering of redeemable convertible preferred shares in 2020 and the sale of common shares in 2021; the company has already paid the fines and strengthened internal processes through staff training.
While the sanctions relate to past events and have no additional impact on current financial statements or operations, the disclosure of past compliance failures may pose a reputational risk for investors.
[AI Summary]Oncocross retrospectively added details of FSS fines in this amended disclosure. The financial impact is negligible as fines were already paid, but the revelation of pre-listing registration failures may erode trust in internal controls and negatively affect short-term stock sentiment.